Analyst Research
| Report Title | Price |
|---|---|
|
Provider: Thomson Reuters Stock Report
|
$25.00
|
|
Provider: Reuters Investment Profile
|
$20.00
|
|
Provider: Wright Reports
|
$483.00
|
|
Provider: GlobalData
|
$125.00
|
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
JW PHARMACEUTICAL Declares Annual Cash Dividend for FY 2011
JW PHARMACEUTICAL announced that its Board of Directors has declared an annual cash dividend of KRW 200 per share of common stock and KRW 225 per share of preferred stock for the fiscal year 2011 to shareholders of record on December 31, 2011. The dividend rates of market prices are 1.3% (common shares) and 1.6% (preferred shares), respectively. The total cash dividend amount is KRW 2,043,504,200. The dividend payment date is April 20, 2012. The Company's annual cash dividend for the fiscal year 2010 was KRW 300 per share of common stock and KRW 325 per share of preferred stock.
Latest Developments for JW Pharmaceutical Corp
Latest Key Developments in Pharmaceuticals
- Valeant Pharmaceuticals International Inc Near Deal To Acquire Bausch & Lomb From Warburg Pincus LLC-Reuters
- Valeant Pharmaceuticals International Inc Near Deal To Acquire Bausch & Lomb-Reuters
- Astec LifeSciences Ltd Recommends Dividend; Announces Appointment Of Statutory Auditors
- J B Chemicals and Pharmaceuticals Ltd Recommends Dividend
- Share this
- Link this
- Digg this


Follow Reuters